| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |